Status:
UNKNOWN
Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19)
Lead Sponsor:
Hospital de Mataró
Conditions:
Covid19
Corona Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Observational and prospective study with one year of follow-up of the cohort of workers of the CSdM, including workers of subcontracted companies working in the Hospital of Mataró (2,300 workers appro...
Detailed Description
* Study design: observational and prospective study with one year of follow-up of the cohort of workers of the CSdM, including workers of subcontracted companies working in the Hospital of Mataró (2,3...
Eligibility Criteria
Inclusion
- All the professionals working at the Consorci Sanitari del Maresme (approximately 2300 subjects).
Exclusion
- None.
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT04425759
Start Date
June 8 2020
End Date
June 30 2021
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Mataró
Mataró, Barcelona, Spain, 08304